tradingkey.logo
tradingkey.logo
Suchen

Procept Biorobotics Corp

PRCT
Zur Watchlist hinzufügen
21.030USD
-2.440-10.40%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.20BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Procept Biorobotics Corp Unternehmen

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Procept Biorobotics Corp Informationen

BörsenkürzelPRCT
Name des UnternehmensProcept Biorobotics Corp
IPO-datumSep 15, 2021
CEOWood (Larry L)
Anzahl der mitarbeiter756
WertpapierartOrdinary Share
GeschäftsjahresendeSep 15
Addresse150 Baytech Drive
StadtSAN JOSE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl95134
Telefon16502329832
Websitehttps://www.procept-biorobotics.com/
BörsenkürzelPRCT
IPO-datumSep 15, 2021
CEOWood (Larry L)

Führungskräfte von Procept Biorobotics Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
4.10K
+80.83%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Procept Biorobotics Corp?

Die fünf größten Anteilseigner von Procept Biorobotics Corp sind: Dr. Frederic H. (Fred) Moll, M.D.

Wie viele Institutionen halten Anteile an Procept Biorobotics Corp (PRCT)?

Mit Stand vom 2026Q1 halten 597 Institutionen Anteile an Procept Biorobotics Corp, mit einem Gesamtmarktwert von etwa 65.01M, was 114.22% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1014187.00 gestiegen.

Was ist die größte Einnahmequelle von Procept Biorobotics Corp?

Am 2026Q1 erzielte das Geschäft mit Hand pieces and other consumables für Procept Biorobotics Corp den höchsten Umsatz in Höhe von 181.45M, was 58.90% des Gesamtumsatzes entspricht.